Tag Archives: Technology Transfer

BIO’s “What Every State Should Know About Bayh-Dole” Webinar

Vaccines Research - Novartis AG

The Biotechnology Industry Organization (BIO) recently hosted a webinar entitled: “What Every State Should Know About Bayh-Dole: Leveraging University Research to Create Jobs and Spur Economic Development Benefits.” The Bayh-Dole Act, enacted in 1980, placed patent ownership of federally funded research at universities in the hands of the university and enabled universities to out-license technologies for commercialization.  As a result of the Act, more than 7200 companies were created (including nearly 600 last year despite Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

NIST Report: Federal Laboratory Technology Transfer Fiscal Year 2009

The National Institute of Standards and Technology in the U.S. Department of Commerce released a report in March discussing Federal Laboratory Technology Transfer for the fiscal year 2009. The report concludes that from the years 2005-2009 the number of new inventions reported declined while new patent applications and issued patents increased.  Standard invention licensing declined while “other” licenses increased.  The report cautions that the numbers do not tell the whole story and they are working to develop Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Bayh-Dole Podcast moderated by BIO with AUTM and patient advocate

Lila Feisee, Vice President for Global Intellectual Property Policy at BIO, moderated a podcast on the benefits of the Bayh-Dole Act and the need to maintain flexibility in our nation’s technology transfer system.  She was joined by: Dr. Ashley Stevens, Special Assistant to the Vice President for Research Technology Development and Senior Research Associate at the Institute for Technology Entrepreneurship & Commercialization at the Boston University School of Management.  He  also serves as President of Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

BIO’s IP Priorities for 2011

As we start a new year, the BIO Intellectual Property Department has determined their 2011 priorities.  Intellectual Property remains a foundational priority for BIO and our 1100 biotechnology company members. BIO’s IP department has approved the following priorities for 2011: 1) PTO reforms to improve efficient, timely and quality examination 2) Congressional patent reform legislation 3) Improving IP protection in key foreign markets 4) IP legal developments in the courts 5) Protecting the breadth and flexibility of the patent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

AUTM U.S. Licensing Survey 2009

AUTM released their 2009 report for technology transfer licensing activities.  Of particular interest is the 596 start-up companies that were created in the middle of an economic recessision.  This Survey suggests that in 2009 Bayh-Dole contributed to growth in an otherwise declining economy, created jobs, and helped fund future research.  Here are the U.S. Highlights: Economic Impact The number of licenses executed increased 5.6 percent, whereas the number of options decreased 3.4 percent. Total licenses and options increased 3.8 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,